Log on / register
Feedback | Support | My details
Open AccessCase report

First documented cure of a suggestive exogenous reinfection in polymyositis with same but multidrug resistant M. tuberculosis

Chiranjoy Mukhopadhyay1,2,3 email, Ankita Garg4 email and Archana Ayyagari5 email

Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebarely Road, Lucknow, Uttar Pradesh, Pin: 226014, India

Current address: Department of Microbiology, Manipal College of Medical Sciences, P.O. Box 155, Deep Heights 16, Pokhara, Nepal

Corresponding address: Department of Microbiology, Manipal College of Medical Sciences, P.O. Box 155, Deep Heights 16, Pokhara, Nepal

Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebarely Road, Lucknow, Uttar Pradesh, Pin: 226014, India

Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebarely Road, Lucknow, Uttar Pradesh, Pin: 226014, India

author email corresponding author email

BMC Infectious Diseases 2004, 4:63doi:10.1186/1471-2334-4-63

Published: 23 December 2004

Abstract

Background

MDR Mycobacterium tuberculosis is the major cause of treatment failure in tuberculosis patients, especially in immunosuppressed. We described a young polymyositis patient on immunosuppressive therapy who was started with antituberculosis therapy as a susceptible strain of M. tuberculosis was isolated from a single cutaneous abscess in his neck and from regional lymph nodes.

Case presentation

He had non-reactive miliary tuberculosis and multiple cutaneous abscesses 6 months later with the same strain, which was resistant this time to 9 antituberculosis drugs. We described clinical presentation, radiological and laboratory work-up, treatment and follow-up as the patient was cured after 1.5 years with 6 antituberculosis drugs.

Conclusion

To our knowledge, this is the first reported case where an immunosuppressed patient with suggestive exogenous reinfection within 6 months with the same but MDR strain of M. tuberculosis was cured. Intense management and regular follow up were important since the patient was a potent source of MDR M. tuberculosis infection and there was limited choice for therapy.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.